Shots:
Matthew spoke about Immunome’s collaboration and option agreement with AbbVie for the discovery of up to 10 novel antibody-target pairs arising from three specified tumor types using Immunome’s Discovery Engine
He also talked about how the partnership with AbbVie can support Immunome’s strategy to maximize the new drug discovery potential of its Discovery Engine…
Shots:
In continuation of our previous series on the top-performing drug of the month, based on 2021 revenue, this month we have selected Dupixent and prepared a curated analysis report for our readers
Dupixent is an interleukin-4 receptor alpha antagonist used for the treatment of multiple indications including atopic dermatitis, asthma, eosinophilic esophagitis, etc.
PharmaShots…
Shots:
Emily spoke about the launch of the new visual identity of Merz Aesthetics. The identity is built on the idea to create a cohesive and clear visual identity for Merz Aesthetics that reflects who they are and the purpose to fuel confidence
The brightness of this new identity includes shades of orange, yellow, green,…
Shots:
Josh spoke about the collaboration with MCI Onehealth. The collaboration will provide access to high-value data insights as a service for an array of research, clinical, and data science needs
Josh also talked about MDClone’s ADAMS platform which has a unique ability to convert datasets and cohorts of interest into synthetic files that are…
Shots:
Jeremiah spoke about Cionic’s recent collaboration with designer Yves Behar and his design firm, fuseproject to deliver its bionic leg wearable to determine human mobility in real-time
He talked about the results from the CIONIC trial and also discussed home usability trials to understand the impact of the Neural Sleeve on mobility over time…
Shots:
Dr.Chez talked about the challenges faced in epilepsy diagnosis and its various treatment options
Greg spoke about the new online series sponsored by Jazz Pharmaceuticals and how it benefits people with Epilepsy
The interview summarizes the vital role of caregivers in the lives of those living with epilepsy
Smriti: Can we talk about Epilepsy in…
Shots:
Kimberly talked about the approval for label update of ViiV’s lead candidate in HIV, and how an optional oral lead-in will be efficient for people receiving it
Kimberly also spoke about ViiV’s collaboration with Janssen for the commercialization of the product
The interview gives an understanding of the different treatment options for HIV and…
In an interview with PharmaShots, Jonathan Wang, Executive Vice President and Head of Business Development at Zai Lab shares his views on the license agreement with Karuna Therapeutics for KarXT (xanomeline-trospium) to treat schizophrenia and psychosis
Shots:
The companies collaborate to develop, manufacture & commercialize KarXT in Greater China including mainland China, Hong Kong, Macau & Taiwan
Zai Lab gets exclusive rights to develop &…
In an interview with PharmaShots, Kevin Cammack, Head of Connected Care, Eli Lilly and Company shares insights on the Lilly alliance with DexCom, Glooko, myDiabby Healthcare, and Roche to provide compatibility between their unique digital management platforms and Lilly's Tempo Pen and Tempo Smart Button.
Shots:
Eli Lilly collaborates with DexCom, Glooko, myDiabby Healthcare, and Roche to…
In an interview with PharmaShots, Marie Schiller Vice President of Product Development for Connected Care and Insulins at Lilly shared her views on its collaboration with Welldoc to integrate Welldoc's insulin management technology into Lilly's connected insulin solutions.
Shots:
Lilly and Welldoc are teaming up to create a new version of Welldoc's BlueStar app which will be integrated…

